Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers
Ahmet Soysal, Erdem Gönüllü, Nalan Karabayır, Servet Alan, Serkan Atıcı, İsmail Yıldız, Havva Engin, Mahmut Çivilibal, Metin Karaböcüoğlu
Abstract
= .032). CoronaVac administration was safe and may elicit higher antibody responses in previously naturally infected individuals.
Topics & Concepts
ReactogenicityMedicineImmunogenicityVaccinationAdverse effectAsymptomaticPneumoniaTiterAntibodyAntibody titerVirologyImmunologyInternal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and Thrombosis